Coldstream Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,495
Closed -$264K 1260
2026
Q1
$264K Sell
3,495
-3,693
-51% -$278K ﹤0.01% 999
2025
Q4
$535K Sell
7,188
-1,658
-19% -$121K 0.01% 696
2025
Q3
$597K Buy
8,846
+953
+12% +$63.3K 0.01% 657
2025
Q2
$514K Buy
7,893
+29
+0.4% +$1.74K 0.01% 645
2025
Q1
$486K Sell
7,864
-2,490
-24% -$165K 0.01% 613
2024
Q4
$746K Buy
10,354
+944
+10% +$73.7K 0.02% 455
2024
Q3
$761K Buy
9,410
+3,388
+56% +$271K 0.02% 459
2024
Q2
$447K Sell
6,022
-83
-1% -$6.22K 0.01% 594
2024
Q1
$476K Buy
6,105
+1,833
+43% +$136K 0.01% 574
2023
Q4
$305K Buy
+4,272
New +$297K 0.01% 699
2023
Q3
Sell
-2,869
Closed -$232K 821
2023
Q2
$232K Buy
2,869
+213
+8% +$17.4K 0.01% 721
2023
Q1
$214K Buy
+2,656
New +$214K 0.01% 756

Other funds holding HOLX

Coldstream Capital Management's HOLX Position: Q2 2026 in Review

Coldstream Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,495 shares — an estimated $264K sold.

Coldstream Capital Management first reported a position in HOLX in Q1 2023 and held it in 12 quarters. The position peaked at $761K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Coldstream Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Coldstream Capital Management sold 3,495 Hologic shares in Q2 2026, an estimated $264K.
  • Coldstream Capital Management first reported a position in Hologic in Q1 2023 and held it in 12 quarters.
  • Coldstream Capital Management's Hologic position peaked at $761K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.